Fig. 9From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseEffects of C6, C7, and galantamine on the passive avoidance task in scopolamine-induced memory deficit model. *P < 0.05 versus vehicle-treated controls. #P < 0.05versus scopolamine-treated group. Data are expressed as mean ± SEM [29]Back to article page